These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23613251)

  • 61. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
    Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
    Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
    Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
    Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
    Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
    Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.
    Schultz IJ; Kiemeney LA; Willems JL; Swinkels DW; Witjes JA; de Kok JB
    Clin Chem; 2006 Jul; 52(7):1440-2. PubMed ID: 16798976
    [No Abstract]   [Full Text] [Related]  

  • 66. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y; Mowla SJ; Ziaee SA
    Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictive values of urinary bladder tumor markers survivin and soluble-Fas comparison with cystoscopy and bladder tumor antigen.
    Ganas V; Kalaitzis C; Sountoulides P; Giannakopoulos S; Touloupidis S
    Minerva Urol Nefrol; 2012 Dec; 64(4):279-85. PubMed ID: 23288215
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.
    Al-Maghrebi M; Kehinde EO; Kapila K; Anim JT
    Med Princ Pract; 2012; 21(3):295-7. PubMed ID: 22236881
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.
    Tokunaga H; Lee DH; Kim IY; Wheeler TM; Lerner SP
    Clin Cancer Res; 1999 Sep; 5(9):2520-5. PubMed ID: 10499628
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Expression of survivin mRNA in urine exfoliated cells of patients with bladder transitional cell carcinoma detected by real-time PCR].
    Sun J; Hou JQ; He J; He XF; Wen DG
    Ai Zheng; 2009 Oct; 28(10):1100-2. PubMed ID: 19799821
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of p53 and mdm2 and their significance in recurrence of superficial bladder cancer.
    Tuna B; Yörükoğlu K; Tüzel E; Güray M; Mungan U; Kirkali Z
    Pathol Res Pract; 2003; 199(5):323-8. PubMed ID: 12908522
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Immunohistochemical analysis of expression of angiogenic factors and tumor angiogenesis in superficial bladder cancer].
    Ogura Y; Sato K; Kato T; Saito K; Enomoto K
    Nihon Hinyokika Gakkai Zasshi; 1998 May; 89(5):529-37. PubMed ID: 9642990
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer.
    Wu Y; Wang G; Wei J; Wen X
    Indian J Med Sci; 2005 Jun; 59(6):235-42. PubMed ID: 15988093
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.
    Poyet C; Thomas L; Benoit TM; Delmo DA; Luberto L; Banzola I; Günthart MS; Sais G; Eberli D; Sulser T; Provenzano M
    Oncotarget; 2017 Mar; 8(13):21871-21883. PubMed ID: 28423532
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder.
    Ku JH; Kwak C; Lee HS; Park HK; Lee E; Lee SE
    J Urol; 2004 Feb; 171(2 Pt 1):631-5. PubMed ID: 14713775
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical significance of urinary vascular endothelial growth factor in patients with superficial bladder tumors.
    Jeon SH; Lee SJ; Chang SG
    Oncol Rep; 2001; 8(6):1265-7. PubMed ID: 11605046
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features.
    Li W; Wang Y; Tan S; Rao Q; Zhu T; Huang G; Li Z; Liu G
    Med Sci Monit; 2018 Oct; 24():7178-7185. PubMed ID: 30296252
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.